{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:46:17Z","timestamp":1774975577482,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejim.2022.09.028","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T09:50:26Z","timestamp":1665395426000},"page":"128-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of factors for persistence of AA amyloidosis in patients with Familial Mediterranean Fever"],"prefix":"10.1016","volume":"108","author":[{"given":"Alexandre","family":"Terr\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Savey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Buob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Grateau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2022.09.028_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101529","article-title":"Systemic autoinflammatory diseases: clinical state of the art","volume":"34","author":"Georgin-Lavialle","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.ejim.2022.09.028_bib0002","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2022.09.028_bib0003","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of Familial Mediterranean Fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2022.09.028_bib0004","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.39995","article-title":"Anakinra for colchicine-resistant Familial Mediterranean Fever: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Ben-Zvi","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ejim.2022.09.028_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejim.2020.11.001","article-title":"Prescription of interleukin-1 inhibitors in a French adult cohort of Familial Mediterranean Fever","volume":"84","author":"Fayand","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2022.09.028_bib0006","first-page":"221","article-title":"Risk factors for amyloidosis and impact of kidney transplantation on the course of Familial Mediterranean Fever","volume":"14","author":"Ben-Zvi","year":"2012","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ejim.2022.09.028_bib0007","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.09.028_bib0008","doi-asserted-by":"crossref","first-page":"130\u20112","DOI":"10.1016\/j.ejim.2020.08.012","article-title":"Georgin-Lavialle S. Cause of death and risk factors for mortality in AA amyloidosis: a French retrospective study","volume":"82","author":"Terr\u00e9","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2022.09.028_bib0009","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.1780401023","article-title":"Criteria for the diagnosis of Familial Mediterranean Fever","volume":"40","author":"Livneh","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2022.09.028_bib0010","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1093\/rheumatology\/keaa863","article-title":"Defining colchicine resistance\/intolerance in patients with Familial Mediterranean Fever: a modified-Delphi consensus approach","volume":"60","author":"\u00d6zen","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejim.2022.09.028_bib0011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000235892","article-title":"Prevention of amyloidosis in Familial Mediterranean Fever with colchicine: a case-control study in Armenia","volume":"18","author":"Sevoyan","year":"2009","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.ejim.2022.09.028_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129.2014.980942","article-title":"Risk factors for AA amyloidosis in Germany","volume":"22","author":"Blank","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.ejim.2022.09.028_bib0013","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/rheumatology\/keaa772","article-title":"Amyloid storm: acute kidney injury and massive proteinuria, rapidly progressing to end-stage kidney disease in AA amyloidosis of Familial Mediterranean Fever","volume":"60","author":"Kukuy","year":"2021","journal-title":"Rheumatology"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522003508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522003508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:37:11Z","timestamp":1760607431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522003508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":13,"alternative-id":["S0953620522003508"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.09.028","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of factors for persistence of AA amyloidosis in patients with Familial Mediterranean Fever","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}